Mylan Stock Buy | Or Sell

Recent FDA warnings and import alerts regarding manufacturing facilities in India (Indore and Nashik) continue to impact EBITDA estimates.

Management expects roughly 2% total revenue growth and strong free cash flow exceeding $2.5 billion . mylan stock buy or sell

The company expects 2026 to be a "pivotal year" with 2% revenue growth and $650 million in planned cost savings. mylan stock buy or sell

Discounted Cash Flow (DCF) models suggest the stock is significantly undervalued, with some estimates placing "fair value" as high as $56.03 . mylan stock buy or sell

Technical analysis indicates a recent "sell signal" from a pivot top point reached in late April 2026. Financial Health & Outlook